G proteins in heart disease

Heart Failure Reviews

Volumn 4, Issue 4, 1999, Pages 303-310

  Dorn II, Gerald W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Cell signaling; Heart failure; Hypertrophy

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; G PROTEIN COUPLED RECEPTOR; INOSITOL TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLAMBAN; PROTEIN G;

APOPTOSIS; DISEASE MODEL; HEART FAILURE; HEART HYPERTROPHY; HUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SWINE; TRANSGENIC MOUSE;

EID: 0033503766     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009895301426     Document Type: Review

References (59)

1. Simon MI, Strathmann MP, Gautam N. Diversity of G proteins in signal transduction. Science 1991;252:802-808.
2. Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet 1988;2:936-937.
3. Hershberger RE, Feldman AM, Bristow MR. A1-adenosine receptor inhibition of adenylate cyclase in failing and non-failing human ventricular myocardium. Circulation 1991;83: 1343-1351.
4. Marzo KP, Frey MJ, Wilson JR, et al. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res 1991;69:1546-1556.
5. Böhm M, Gierschik P, Knorr A, Larisch K, Weismann K, Erdmann E. Desensitization of adenylate cyclase and increase of Gi alpha in cardiac hypertrophy due to acquired hypertension. Hypertension 1992;20:103-112.
6. Böhm M, Gierschik P, Knorr A, Larisch K, Weismann K, Erdmann E. Role of altered G-protein expression in the regulation of myocardial adenylate cyclase activity and force of contraction in spontaneous hypertensive cardiomyopathy in rats. J Hypertens 1992;10:1115-1128.
7. Kawamoto H, Ohyanagi M, Nakamura K, Yamamoto J, Iwasaki T. Increased levels of inhibitory G protein in myocardium with heart failure. Jpn Circ J 1994;58:913-924.
8. Böhm M, Kirchmayr R, Erdmann E. Myocardial Gi alpha-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock. Cardiovasc Res 1995;30:611-618.
9. Vatner DE, Sato N, Galper JB, Vatner SF. Physiological and biochemical evidence for coordinate increases in muscarinic receptors and Gi during pacing-induced heart failure. Circulation 1996;94:102-107.
10. Feldman AM, Cates AE, Bristow MR, Van Dop C. Altered expression of alpha-subunits of G proteins in failing human hearts. J Mol Cell Cardiol 1989;21:359-365.
11. Feldman AM, Ray PE, Bristow MR. Expression of alpha-subunits of G proteins in failing human heart: A reappraisal utilizing quantitative polymerase chain reaction. J Mol Cell Cardiol 1991;23:1355-1358.
12. Eschenhagen T, Mende U, Nose M, et al. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ Res 1992;70: 688-696.
13. Eschenhagen T, Friedrichsen M, Gsell S, et al. Regulation of the human Gi alpha-2 gene promoter activity in embryonic chicken cardiomyocytes. Basic Res Cardiol 1996;91:41-46.
14. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in dilated cardiomyopathy (MDC) trial study group. Lancet 1993;342:1441-1446.
15. Sigmund M, Jakob H, Becker H, et al. Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure. Eur J Clin Pharmacol 1996;51:127-132.
16. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992;327:669-677.
17. Jakob H, Sigmund M, Eschenhagen T, et al. Effect of captopril on myocardial beta-adrenoceptor density and Gi alpha-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy. Eur J Clin Pharmacol 1995;47: 389-394.
18. Redfern CH, Coward P, Degtyarev MY, et al. Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol 1999;17:165-169.
19. Chen LA, Vatner DE, Vatner SF, Hittinger L, Homcy CJ. Decreased Gs alpha mRNA levels accompany the fall in Gs and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses. J Clin Invest 1991; 87:293-298.
20. Longabaugh JP, Vatner DE, Vatner SF, Homey CJ. Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure. J Clin Invest 1988;81:420-424.
21. Sethi R, Elimban V, Chapman D, Dixon IM, Dhalla NS. Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol 1998;30:2153-2163.
22. Roth DA, Urasawa K, Helmer GA, Hammond HK. Down-regulation of cardiac guanosine 5′-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J Clin Invest 1993;91:939-949.
23. Bohm M, Gierschik P, Knorr A, Schmidt U, Weismann K, Erdmann E. Cardiac adenylyl cyclase beta-adrenergic receptors, and G proteins in salt-sensitive hypertension. Hypertension 1993;22:715-727.
24. Brodde OE, Vogelsang M, Broede A, et al. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: No difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 1998;4:585-594.
25. Sethi R, Bector N, Takeda N, Nagano M, Jasmin G, Dhalla NS. Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters. Mol Cell Biochem 1994;140:163-170.
26. Gaudin C, Ishikawa Y, Wight DC, et al. Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest 1995;95:1676-1683.
27. sα overexpression. Circ Res 1996;78:517-524.
28. sα transgenic mice. Circ Res 1999;84:34-42.
29. Behrana AJ, Hasleton P, Leen CLS, Ashleigh RS, Gholkar A. Multiple extra-adrenal paragangliomas associated with catecholamine cardiomyopathy. Eur Heart J 1989;10: 182-185.
30. Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED Jr. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med 1987;316:793-797.
31. Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocytoma. N Engl J Med 1966; 274:1102-1108.
32. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J 1990;63:234-237.
33. 2 adrenergic receptor overexpression in mouse hearts: Critical role for expression level. Circulation 2000: in press.
34. 2-adrenergic receptors differentially affects cardiac hypertrophy and function in Gαq overexpressing mice. Proc Natl Acad Sci USA 1999;96: 6400-6405.
35. Gao MH, Lai NC, Roth DM, et al. Adenylycyclase increases responsiveness to catecholamine stimulation in transgenic mice. Circulation 1999;99:1618-1622.
36. Rockman HA, Chien KR, Choi DJ, et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA 1998;95:7000-7005.
37. Kock WJ, Rockman HA, Samama P, et al. Cardiac function in mice overexpressing the ß-adrenergic receptor kinase or a ARK inhibitor. Science 1995;268:1350-1353.
38. 2-adrenergic receptor. Science 1994;264:582-586.
39. 1 adrenergic response. J Clin Invest 1983;72:732-738.
40. 2α stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem 1996;71:1179-1186.
41. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 1993;268:15374-15380.
42. Sadoshima J-I, Xu Y, Slayer HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977-984.
43. Shubeita HE, McDonough PM, Harris AN, et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 1990;265:20555-20562.
44. 2+-sensitive isoforms in the failing human heart. Circulation 1999;99:384-391.
45. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
46. Dunn FG, Oigman W, Ventura HO, Messeri FH, Kobrin I, Frohlich ED. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol 1984;53: 105-108.
47. Garavaglia GE, Messeri FH, Nunez BD, Schmieder RE, Frohlich ED. Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (Lisinopril) in essential hypertension. Am J Cardiol 1988;62:912-916.
48. Nakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 1984;53:1044-1049.
49. qα and PLC-β in scar and border tissue in heart failure due to myocardial infarction. Circulation 1998;97:892-899.
50. Milano CA, Dolber PC, Rockman HA, et al. Myocardial expression of a constitutively active α1β-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 1994;91:10109-10113.
51. 1B-adrenergic receptors. J Biol Chem 1997;272:21253-21259.
52. D'Angelo DD, Sakata Y, Lorenz JN, et al. Transgenic Gαq overexpression induces cardiac contractile function in mice. Proc Natl Acad Sci USA 1997;94:8121-8126.
53. Adams JW, Sakata Y, Davis MG, et al. Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 1998;95:10140-10145.
54. Dorn GW, II, Robbins J, Ball N, Walsh RA. Myosin heavy chain regulation and myocyte contractile depression after left ventricular hypertrophy in aortic banded mice. Am J Physiol 1994;267:H400-H405.
55. Sakata Y, Lorenz JN, Hoit BD, Liggett SB, Walsh RA, Dorn GW II. Decompensation of pressure overload hypertrophy in Gαq overexpressing mice. Circulation 1998;97:1488-1495.
56. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ. Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 1998;95:13893-13898.
57. q. Proc Natl Acad Sci USA 1997;94:14089-14094.
58. Offermanns S, Toombs CF, Hu Y-H, Simon MI. Defective platelet activation in Gαq deficient mice. Nature 1997;389: 183-186.
59. 11 mutant mice. EMBO 1998;17:4304-4312.